Setrusumab

setrusumab · Ultragenyx Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Setrusumab, covering 2025-07-23 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta [Phase 3]